On the morning of March 28th, Li Peilin, Deputy Director of the Resource Allocation and Management Division of the Shandong Provincial Department of Science and Technology, and Jiang Ningpeng, Deputy Researcher of the Shandong Provincial Science and Technology Service Development Promotion Center and Chief of the Science and Technology Finance Section, accompanied by Li Xueyong, Deputy Director of the Liaocheng Municipal Science and Technology Bureau, Feng Kai, Deputy Director of the Development Zone Management Committee, and Du Baodong, Director of the Economic Development Department of the Development Zone Management Committee, visited Linchuan Cheng Pharmaceutical for research and guidance. Liu Yanchao, chairman of Chuancheng Pharmaceutical, and Zhang Zhankun, company consultant, accompanied the event.

The research team first watched a video introduction to the company's business situation, then visited the company's showroom and learned about the production status of the workshop through real-time monitoring. Zhang Zhankun gave a detailed introduction to the company's operation and development, focusing on the company's technical research and development, foreign technical cooperation, product production, registration and application work.

The research team fully affirmed the progress of Chuancheng Pharmaceutical's innovation and development work, provided guidance on the company's technology research and development, and distributed promotional materials such as the comprehensive policy compilation of science and technology benefits for enterprises in Shandong Province on the spot, detailing policies such as innovative development and resource docking for service enterprises, providing guarantee for promoting enterprise development.

Liu Yanchao expressed sincere gratitude to the leadership of the Provincial Department of Science and Technology for their guidance and concern. Chuancheng Pharmaceutical will use the technology and financial service system established by the government, which focuses on technology credit, risk compensation, equity investment, and listing cultivation, as a platform to strive for advantageous resources from all parties, strive to seek resource complementarity, increase technological transformation and innovation, promote the transformation of scientific and technological achievements, and promote the rapid growth of enterprises.